Baird Medical Investment Holdings Ltd. ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced new clinical progress across the ...
The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.
Halozyme Therapeutics, Inc. ("Halozyme") today announced that Dr. Helen Torley, President and Chief Executive Officer, is ...
Element Biosciences Inc. today announced VITARI, the first ever high-throughput benchtop sequencing system capable of delivering a high-quality whole genome at $100. With the introduction of VITARI, ...